Diabetes

This Continuing Education activity is supported by an educational grant from AstraZeneca LP and Novo Nordisk, Inc

This Continuing Education activity is supported by an educational grant from Sanofi-Aventis U.S.

Here are new drugs for 2015 pharmacists can expect to handle.

A study evaluating the cardiovascular safety of Merck's type 2 diabetes drug sitagliptin determined the dipeptidyl peptidase-4 inhibitor does not increase the risk for heart failure hospitalization.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some strategies to overcoming patient barriers to insulin.

For each 10 beats per minute increase in heart rate, patients faced a 23% greater risk of diabetes.

Extracts show strong activity in treatment of cervical cancer cells.

Patients with a fast resting heart rate may have a higher risk of developing type 2 diabetes.

Treatment is the first concentrated mealtime insulin analog to be approved by the FDA.

The FDA today approved a new 200 unit/mL formulation of Lilly's Humalog KwikPen for patients with type 1 and type 2 diabetes.

Drug mitigates elevated cardiovascular risk in infected patients.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses the role pharmacists can play when helping clinicians overcome barriers to initiating insulin use.

Both exercise and calorie restriction have additive beneficial effects.

Ranibizumab (Lucentis), a prescription drug frequently used to treat age-related vision loss, can also improve vision in patients with diabetic retinopathy and diabetic macular edema, a recent study indicated.

Type 2 diabetes drugs could lead to complications that cause hospitalization.

The advantages offered by insulin pens may help improve patient adherence.

In patients at risk for type 2 diabetes, diet and exercise have beneficial effects on regulating glucose levels beyond those associated with weight loss.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some barriers clinicians may face to initiating insulin use.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses how pharmacists can help their patients who take insulin.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some barriers patients may have to starting insulin.

Taking statins associated with greater likelihood of developing diabetes with complications.

Even healthy adults taking statins are 87% more likely to develop diabetes.

Although metformin can help prevent diabetes onset in those at high risk, the medication is rarely prescribed for this purpose.

Gene may help identify clue to separation of overactive and underactive immune activity.